Application no. and date | 11714079.8 (espacenet) (Federated) (European Patent Register), 20110331 | Patent/reg. no. and date | DK/EP 2552910, 20150311 | Publication date | 20130206 | Priority no. and date | GB 1005623, 20100401, GB 201005623, 20100401, US 347048 P, 20100521 | EP pub. no. and date |
EP 2552910 20130206 | Effective date | | Applicant/owner | Vantia Limited, Epsilon House, Enterprise Road,
Southhampton Science Park, Southhampton, SO16 7NS, GB | Applicant ref. no. | P55530DK01 | Inventor | KJELLSTRÖM, Johan, Henrik, Ferring Pharmaceuticals A/S Late Stage Development Global Pharmaceutical R&D Kay Fiskers Plads 11, 2300 København S, DK, JOHANSON, Björn, Erik, Vimpelgatan 35
S-211 14 malmö, SE, VILHELMSEN, Thomas, Bygaden 8 Karlstrup, 2690 Karlslunde, DK | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/53 (2006.01) , A61P 13/00 (2006.01) , A61P 13/02 (2006.01) , C07D 409/12 (2006.01) | Title | NY POLYMORF | Int. application no. | GB2011000500 | Int. publication no. | WO2011121308 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|